Omeros (OMER) Non Operating Income (2010 - 2022)
Omeros' (OMER) quarterly Non Operating Income came in at $670000.0 in Q2 2022, up 101.2% year-on-year from $333000.0 in Q2 2021, and up 35.9% quarter-over-quarter from $493000.0 in Q1 2022.
Omeros (OMER) Non Operating Income (2010 - 2022) Analysis & Trends
Omeros has disclosed Non Operating Income across 13 years of filings, most recently posting $670000.0 for Q2 2022.
- Non Operating Income for Q2 2022 came in at $670000.0, up 101.2% year-over-year; the trailing twelve-month figure through Jun 2022 was $2.2 million (up 336.99% YoY), and the FY2021 annual result was $1.7 million, up 166.06% from the prior year.
- Non Operating Income came in at $670000.0 for Q2 2022 at Omeros, up from $493000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $670000.0 in Q2 2022 to a low of -$633000.0 in Q3 2020.
- The 5-year median for Non Operating Income is $439000.0 (2018), against an average of $382833.3.
- Across the five-year window, Non Operating Income plunged 279.32% in 2020 and jumped 172.83% in 2021, its largest moves.
- Omeros' Non Operating Income stood at $153000.0 in 2018, then soared by 90.85% to $292000.0 in 2019, then climbed by 28.08% to $374000.0 in 2020, then soared by 40.64% to $526000.0 in 2021, then rose by 27.38% to $670000.0 in 2022.
- The last three Non Operating Income figures came in at $670000.0 (Q2 2022), $493000.0 (Q1 2022), and $526000.0 (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 670,000.00 |
| Mar 31, 2022 | 493,000.00 |
| Dec 31, 2021 | 526,000.00 |
| Sep 30, 2021 | 461,000.00 |
| Jun 30, 2021 | 333,000.00 |
| Mar 31, 2021 | 418,000.00 |
| Dec 31, 2020 | 374,000.00 |
| Sep 30, 2020 | -633,000.00 |
| Jun 30, 2020 | 364,000.00 |
| Mar 31, 2020 | 549,000.00 |
| Dec 31, 2019 | 292,000.00 |
| Sep 30, 2019 | 353,000.00 |
| Jun 30, 2019 | 415,000.00 |
| Mar 31, 2019 | 494,000.00 |
| Dec 31, 2018 | 153,000.00 |
| Sep 30, 2018 | 572,000.00 |
| Jun 30, 2018 | 597,000.00 |
| Mar 31, 2018 | 460,000.00 |
| Dec 31, 2017 | 434,000.00 |
| Sep 30, 2017 | 408,000.00 |